Pharma Journalist - Page 44 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Genprex Secures U.S. Patent Protecting REQORSA and PD-L1 Antibody Combination

J&J to Acquire Halda Therapeutics in $3.05B Cancer Therapy Deal

EMA Panel Backs High-Dose SPINRAZA Regimen for Spinal Muscular Atrophy

Johnson & Johnson to Acquire Halda Therapeutics for $3.05B to Expand Oncology Pipeline

Merus and Halozyme Partner to Develop Subcutaneous Version of Petosemtamab

Solve Therapeutics Raises $120M to Advance Next-Generation ADC Platform

Sofinnova Partners Closes €650M Fund to Boost Next-Generation Biotech and Medtech Startups

FDA Updates Safety Label for ELEVIDYS Gene Therapy for Duchenne Muscular Dystrophy

FDA Approval of KOMZIFTI Marks Major Step for Hard-to-Treat AML

UK Approves Monthly Maintenance Dosing for Alzheimer’s Drug Leqembi